Diabetes and Cirrhosis Are Risk Factors for Hepatocellular Carcinoma After Successful Treatment of Chronic Hepatitis C | Zendy

Magnus Hedenstierna | Zendy; A. Nangarhari | Zendy; Ola Weiland | Zendy; Soo Aleman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Diabetes and Cirrhosis Are Risk Factors for Hepatocellular Carcinoma After Successful Treatment of Chronic Hepatitis C

Author(s) -

Magnus Hedenstierna,

A. Nangarhari,

Ola Weiland,

Soo Aleman

Publication year - 2016

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciw362

Subject(s) - medicine , hepatocellular carcinoma , cirrhosis , diabetes mellitus , gastroenterology , chronic hepatitis , carcinoma , hepatitis c , risk factor , immunology , virus , endocrinology

Successful treatment of hepatitis C virus (HCV) infection reduces the risk for hepatocellular carcinoma (HCC), but a risk remains. Current guidelines recommend continued HCC surveillance after sustained virologic response (SVR) has been achieved. This study aimed to investigate risk factors and incidence rates for HCC after SVR in HCV patients with pretreatment advanced liver disease (Metavir stage F3/F4).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research